ROLE OF LYMPHDISSECTION IN THE SURGICAL TREATMENT OF RENAL-CELL CARCINOMA,
https://doi.org/10.17650/1726-9776-2009-5-3-13-15
Abstract
Background: to define interrelation of lymphdissection at radical nephrectomy in surgical treatment of renal cell carcinoma (RCC).
Materials and methods: 221 patients were investigated with RCC. The men — 119, women — 102. Middle age of patients has made 53,3 years. T1 stage in 16 patients (7.3 %), T2 — in 55 patients (24.8 %), T3-133 (60.2%), T4-17(7.7%) patients. N1 occurred in 22 (9.9 %) patients, N2 in 8 (3.6 %), N0 in 191 (86.5 %) patients. Patients were divided into 2 groups depending on volume of lymphdissection, with the period of supervision of 3 years.
Results: Group I. Simple nephrectomy was executed in 130 patients without removal of regional lymph nodes. Metastases during the postoperative period occurred in the remote organs in 25.1 % cases, loco-regional metastasis in lymph nodes in 3.8 % cases was revealed, relapse 3%. Average life expectancy has made 25,6 months (of calculation 3 years). Group II. Nephrectomy with expanded lymphdissection from legs of a diaphragm to bifurcation of illiac arteries by midline approach was performed in 91 patients. On pathogistological research, metastases in regional lymph node was revealed in 15.3 % cases. Metastases during the postoperative period occurred in the remote organs in 6.6 % cases, metastasises in kept away lymph node in 1.08 % cases was revealed, relapse 3,2%. Average life expectancy has made 33,4 months (of calculation 3 years).
Conclusion: we have come to opinion on inexpediency of performance usual nephrectomy on RCC. Application expanded lymphdissection from from legs of a diaphragm to bifurcation of illiac arteries is improved by the remote results.НапоминаемAbout the Authors
M. N. TillyashaikhovUzbekistan
N. M. Rakhimov
Uzbekistan
References
1. Велиев Е.И., Богданов А.Б. Особенности метастазирования рака почки, хирургическое лечение рецидивов и метастазов. Практ онкол 2005;6(3).
2. Давыдов М.И., Матвеев В.Б. Хирургическое лечение местно-распространенного и метастатического рака почки. М., 2002. с. 35—6.
3. Наврузов С.Н., Гафур-Ахунов М.А., Алиева Д. Перспективы развития и совершенствование онкологическорй службы в Узбекистане. В сб.: Проблемы онкологии. Вып. 1. Ташкент, 2002. с. 3—8.
4. Robson C.S., Churchill B.M., Anderson W. The results of radical nephrectomie for renal cell carcinoma. J Urol 1969;101:297.
5. Devita V.T. Principles and practice of Oncology. 5th ed. Philadelphia: Lippncott-Raven, 1997.
6. Мавричев А.С., Суконко О.Г., Красный С.А. Научно-практическая конференция онкологов республики Беларусь: тезисы докладов. Минск, 1994.
7. Mikisch G.H.J. Lymph node dissection for renal cell carcinoma — the value of operation and adjuvant therapy. Urology 1999;38:326—31.
8. Шер Х., Мотцер Р. Злокачественные опухоли почек и мочевых путей. В кн.: Внутренние болезни. Под ред. Т.Р. Харисона. М.: Практика, 2002. с. 710—6.
9. Переверзев А.С., Щукин Д.В. Роль МРТ в диагностике забрюшинной лимфоаденопатии при ангиолипоме и рака почки. Онкология 2000;2(4).
Review
For citations:
Tillyashaikhov M.N., Rakhimov N.M. ROLE OF LYMPHDISSECTION IN THE SURGICAL TREATMENT OF RENAL-CELL CARCINOMA,. Cancer Urology. 2009;5(3):13-15. (In Russ.) https://doi.org/10.17650/1726-9776-2009-5-3-13-15